DLA Piper has confirmed its role in the acquisition by Pfizer of the commercial division of vaccines from Baxter.
Pfizer acquired a portfolio of two vaccines and the corresponding Austrian production facilities in Orth an der Donau. The two vaccines can protect against certain forms of meningitis, partially transmitted through tick bites. Following the completion of the transaction Pfizer will have its own production site in Austria.
The DLA Piper team advising Pfizer in Austria consisted of Partner Christoph Mager, the Head of Corporate for DLA Piper in Austria, and Senior Lead Lawyer Elisabeth Stichmann.
Internationally Pfizer was represented by the US law firm Kirkland & Ellis, while Baxter was advised by Shiva Austin internationally, and by Wolf Theiss in Austria. Tax advice was provided by Deloitte for Pfizer and PwC for Baxter.